HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stimulation of α7 nicotinic acetylcholine receptor by AR-R17779 suppresses atherosclerosis and aortic aneurysm formation in apolipoprotein E-deficient mice.

Abstract
Atherosclerosis is a chronic inflammatory disease. It has been appreciated that vagus nerve inhibits macrophage activation via α7 nicotinic acetylcholine receptor (nAChR), termed the cholinergic anti-inflammatory pathway. We explored the effects of AR-R17779, a selective α7nAChR agonist, on atherosclerosis and aneurysm formation in apolipoprotein E (ApoE)-deficient mice. ApoE-deficient mice were fed a high-fat diet (HFD) and angiotensin II (Ang II) was infused by osmotic minipumps from 10-week-old for 4weeks. AR-R17779 was given in drinking water ad libitum. Oil red O staining of the aorta showed that combined loading of HFD and Ang II induced marked atherosclerosis compared with control mice fed a normal chow. Treatment with AR-R17779 significantly reduced atherosclerotic plaque area and improved survival of mice. Treatment with AR-R17779 also suppressed abdominal aortic aneurysm formation. Quantitative RT-PCR of the aorta revealed that mRNA expression levels of interleukin-1β, interleukin-6 and NOX2 were significantly decreased in AR-R17779-treated mice compared with Ang II+HFD mice. AR-R17779 treatment also reduced blood pressure and serum lipid levels. In conclusion, α7nAChR activation attenuates atherogenesis and aortic abdominal aneurysm formation in ApoE-deficient mice possibly through an anti-inflammatory effect and reduction of blood pressure and lipid levels. Pharmacological activation of α7nAChR may have a therapeutic potential against atherosclerotic vascular diseases through multiple mechanisms.
AuthorsToru Hashimoto, Toshihiro Ichiki, Aya Watanabe, Eva Hurt-Camejo, Erik Michaëlsson, Jiro Ikeda, Eriko Inoue, Hirohide Matsuura, Tomotake Tokunou, Shiro Kitamoto, Kenji Sunagawa
JournalVascular pharmacology (Vascul Pharmacol) 2014 May-Jun Vol. 61 Issue 2-3 Pg. 49-55 ISSN: 1879-3649 [Electronic] United States
PMID24685818 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • AR-R 17779
  • Anti-Inflammatory Agents
  • Apolipoproteins E
  • Bridged-Ring Compounds
  • Lipids
  • Spiro Compounds
  • alpha7 Nicotinic Acetylcholine Receptor
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Aortic Aneurysm (prevention & control)
  • Apolipoproteins E (genetics)
  • Atherosclerosis (prevention & control)
  • Blood Pressure (drug effects)
  • Bridged-Ring Compounds (pharmacology)
  • Disease Models, Animal
  • Lipids (blood)
  • Male
  • Mice
  • Mice, Knockout
  • Rats
  • Rats, Sprague-Dawley
  • Spiro Compounds (pharmacology)
  • alpha7 Nicotinic Acetylcholine Receptor (agonists, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: